Creative Biolabs offers an HPLC-MS/MS-based Cytochrome P450 3A (CYP3A) Inhibition Assessment Service that provides a comprehensive analysis of drug candidates to determine their potential to inhibit the CYP3A enzyme. This service leverages state-of-the-art technology to deliver accurate and reliable results, helping you identify potential interactions and evaluate the safety and efficacy of new compounds. The following is our HPLC-MS/MS-based CYP inhibition assessment service platform, which includes different cytochrome P450 inhibition assessment and detection services.
CYP3A is a family of enzymes that belongs to the cytochrome P450 superfamily of enzymes. CYP3A is mainly distributed in the liver and is involved in the metabolism of a variety of drugs, toxins, and endogenous compounds. CYP3A enzymes are responsible for metabolizing approximately 50% of all clinically used drugs, making them one of the most important drug-metabolizing enzymes in the body.
The HPLC-MS/MS-based Cytochrome P450 3A (CYP3A) Inhibition Assessment Service at Creative Biolabs typically includes the following:
| Protein Name | Family | Sub Family | Uniprot Number | Gene Name |
| CYP3A4 | CYP450 | CYP3 | P08684 | CYP3A4 |
| Gene ID | Gene Aliases | Organism | Construct Details | Tissue |
| 1576 | CYPIIIA4 |P450-III | Human | Microsomes | Liver |
Service Type
Biochemical
Function Mode
Antagonist
Measured Response
Peak Area Response
Service Sub Type
Enzymatic
Detection Method
HPLC-MS/MS
Substrate
Testosterone or Midazolam
Accurate and reliable, providing clients with trustworthy data that you can confidently use in your drug development processes.
A fast turnaround time for the assessment services for clients, enabling you to make timely decisions regarding your drug development strategies.
Have a team of experts with relevant experience in conducting CYP3A inhibition assessments using HPLC-MS/MS, ensuring that the results are of the highest quality.
Creative Biolabs provides customized solutions based on the specific needs of each client.
Creative Biolabs provided exceptional customer service throughout the assessment process, including clear communication, responsiveness, and support.
A1: Why do CYP1A inhibition assessment?
Q1: Assessing CYP1A inhibition is important for ensuring the safety and efficacy of drugs and other compounds in development, as well as understanding the potential health risks associated with exposure to environmental toxins. CYP1A enzymes are involved in the metabolism of many medications, including commonly prescribed drugs such as theophylline, caffeine, and some anticancer drugs. CYP1A enzymes are also involved in the metabolism of certain environmental pollutants, such as polycyclic aromatic hydrocarbons (PAHs) and dioxins. Inhibiting CYP1A can lead to the accumulation of these toxic compounds in the body, increasing the risk of adverse health effects.
If you have any inquiries or would like more information about our HPLC-MS/MS-based Cytochrome P450 3A (CYP3A) inhibition assessment service, please feel free to contact us. We look forward to hearing from you! As a professional service provider in the field of immuno-oncology, Creative Biolabs also provides you with the following services: